Active Ingredients
8.26 mg estradiol 0.5 water
Excipients
Pegoterat
Soybean oil, refined
Poly[(2-ethylhexyl)acrylate-co-methylacrylate-co-acrylic acid-co-(2,3-epoxypropyl)methacrylate] (62.2:32:5.7:0.03)
Preparation of (R,R,R)-α-tocopherol
ESTRAMON® UNO 100 patches
for hormone replacement therapy of symptoms caused by a lack of the female sex hormone estrogen in women during and after menopause.
to prevent osteoporosis (bone loss) if you are at high risk of future bone fractures and cannot tolerate or are not allowed to use other medications used for this purpose. Your doctor should discuss available treatment options with you.
Experience in treating women over 65 years of age is limited.
It will be
Used for hormone replacement therapy for symptoms caused by a deficiency of the female sex hormone estrogen in women during and after menopause.
to prevent osteoporosis (bone loss) if you are at high risk of future bone fractures and cannot tolerate or are not allowed to use other medications used for this purpose. Your doctor should discuss available treatment options with you.
Experience in treating women over 65 years of age is limited.
Compound:
1 transdermal patch with an area of 40 cm2 contains: 8.26 mg estradiol hemihydrate, which is equivalent to 8 mg estradiol.
Average estradiol release per day: 100 micrograms, Other Ingredients: Matrix: acrylate copolymer, RRR-alpha tocopherol formulation (USP), carrier film: polyethylene terephthalate, protective film: polyethylene terephthalate, siliconized.
Application:
Always use Estramon® UNO 100 exactly as your doctor has advised you. If you are unsure, ask your doctor or pharmacist.
